• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Blue Water Ventures International Inc (OP: BWVI )

    0.0001 UNCHANGED
    Last Price Updated: 2:24 PM EDT, Oct 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 0.0001
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.0001
    Today's Range 0.0001 - 0.0001
    52wk Range 0.0001 - 0.0800
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    I Saw Trillions Of Atoms In My Hand Vibrating At A Certain Frequency, Says Zappy Zapolin Describing His First Psychedelics Experience
    Via Benzinga
    Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical Biosciences
    Via ACCESSWIRE

    Performance

    YTD
    -99.84%
    -99.84%
    1 Month
    N/A
    N/A
    3 Month
    -94.44%
    -94.44%
    6 Month
    -96.88%
    -96.88%
    1 Year
    -99.83%
    -99.83%

    More News

    Read More
    Psychedelics 2024: Veterans Blessing, Mental Health Paradigm Shift, Providers Training, Ketamine-MDMA Bonds & More
    Via Benzinga
    Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream'
    Via Benzinga
    Psycheceutical Bioscience Strategically Pivots Into the Brain-Computer Interface (BCI) Space
    Via ACCESSWIRE
    Dr. Neilank Jha Appointed as Executive Chairman and Chief Executive Officer of Psycheceutical Bioscience Inc.
    Via ACCESSWIRE
    Psycheceutical Bioscience Launches Wefunder Crowdfunding Campaign for Safer Psychedelic Dosing
    Via ACCESSWIRE
    Shark Tank's Kevin Harrington Leads Crowdfunding Campaign For Psycheceutical Bioscience (OTCPK: BWVI)
    Via Benzinga
    Treating PTSD Topically & Directly To The Brain? Psychedelics Delivery Company Poised For Major Breakthrough
    Via Benzinga
    Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD
    Via ACCESSWIRE
    Psycheceutical Bioscience Announces Completion of PCAOB Audit and Future Corporation Action Strategy
    Via ACCESSWIRE
    First Patient Dosed in Psycheceutical's Phase I Study Exploring Topical Administration of Ketamine to Treat PTSD
    Via ACCESSWIRE
    Video: 'Moms On Mushrooms Are Gonna Change The Whole Society,' Says Zappy Zapolin Before Presenting Rick Doblin Award
    Via Benzinga
    EXCLUSIVE: Lessons From Psychedelics Markets Through Business, Legal And Reciprocity Lenses
    Via Benzinga
    Zappy Zapolin Talks Psychedelics And Breakthrough Delivery Methods: The Future Has Arrived And It's Awesome
    Via Benzinga
    The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s (OTCPK:BWVI) Novel Topical Ketamine Delivery
    Via ACCESSWIRE
    Psyched: MDMA Therapy Advances With FDA, Alternatives For Alcohol Addiction, Prince Harry In The Spotlight And More
    Via Benzinga
    This Groundbreaking Ketamine Topical Cream Is Capturing Rick Doblin's Attention
    Via Benzinga
    What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry
    Via Benzinga
    Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab
    From Psycheceutical Bioscience, Inc.
    Via GlobeNewswire
    What If There Was A Topical Cream That Treated PTSD Without Side Effects? — Psycheceutical Bioscience, Inc (OTCPK: BWVI) Is Pioneering A Possible Solution
    Via News Direct
    What If There Was A Topical Cream That Treated PTSD Without Side Effects? — Psycheceutical Bioscience, Inc (OTCPK: BWVI) Is Pioneering A Possible Solution
    Via TheNewswire.com
    Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
    Via Benzinga
    Breakthrough Treatment For PTSD? This Ketamine Cream Showing Promise In Alleviating Symptoms
    Via Benzinga
    Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD
    From Psycheceutical Bioscience, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.